About This Calculator
The Docetaxel Dose Calculator is a clinical support tool designed for healthcare professionals to determine patient-specific dosing based on body surface area (BSA). It accommodates various oncologic indications, including breast cancer, non-small cell lung cancer (NSCLC), prostate cancer, gastric adenocarcinoma, and head and neck cancer. This calculator facilitates accurate dose determination by incorporating key patient parameters and allowing for common clinical adjustments.
Calculator Outputs
Upon entering the required patient data, the calculator provides a comprehensive summary of the dosing regimen:
- Final Calculated Dose: The total dose in milligrams (mg), rounded to the nearest whole number, after all adjustments have been applied.
- Calculation Breakdown: A transparent view of how the final dose was derived, including:
- The patient's calculated Body Surface Area (BSA) in m².
- The base dose calculated from BSA and the prescribed mg/m² rate.
- A note on any adjustments made for hepatic function.
- Confirmation of whether dose capping was applied and the limit used.
- Clinical Warnings: Important alerts, such as contraindications for severe hepatic impairment or recommendations for close monitoring in patients with mild impairment.
How to Use the Tool
To calculate a dose, follow these steps:
- Enter Patient Data: Input the patient's height, weight, age, and gender. You can use either metric (cm, kg) or imperial (in, lbs) units.
- Select Clinical Indication: Choose the appropriate cancer type from the dropdown menu. This will populate the standard dose of 75 mg/m². Select "Custom Regimen" to enter a different dose rate.
- Define Dosing Parameters:
- Confirm or adjust the Prescribed Dose in mg/m².
- Select the BSA Formula (Du Bois or Mosteller).
- Specify the patient's Hepatic Function (Normal, Mild Impairment, or Moderate/Severe Impairment).
- Apply Dose Capping (Optional): If required by institutional policy, check "Apply Dose Capping" and enter a maximum BSA (m²) or absolute dose (mg).
- Calculate: Click the "Calculate Dose" button to view the results. All calculations should be independently verified before clinical use.
Dosing Overview
Docetaxel is typically administered as an intravenous infusion over one hour every three weeks. A common dosage for many solid tumors is 75 mg/m². The dose is always calculated based on the individual patient's BSA. Premedication is critical to reduce the incidence and severity of hypersensitivity reactions and fluid retention. The standard premedication regimen is oral dexamethasone (e.g., 8 mg twice daily) for 3 days, starting 1 day before docetaxel administration.
Switching and Dose Adjustments
Dose adjustments for subsequent cycles of docetaxel may be necessary based on patient tolerance and observed toxicities. Patients who experience febrile neutropenia, severe or cumulative skin toxicity, or other grade 3/4 non-hematological toxicities during therapy should have their dose reduced for subsequent cycles. Switching from or to other chemotherapy agents should be done according to established clinical guidelines and protocols, considering washout periods and overlapping toxicities.
Missed Dose Protocol
If a patient misses a scheduled docetaxel infusion, the dose should be rescheduled as soon as medically appropriate. The treatment team will determine the best course of action based on the patient's condition and the overall treatment plan. It is important to adjust the schedule for subsequent cycles accordingly to maintain the intended treatment interval as closely as possible.
Safety Alerts
Healthcare professionals must be aware of several key safety considerations when administering docetaxel. This calculator incorporates a critical safety check for liver function.
Hepatic Impairment Contraindication: Docetaxel is generally contraindicated in patients with bilirubin levels above the upper limit of normal (ULN), or with AST/ALT >1.5 × ULN and alkaline phosphatase >2.5 × ULN. Administration in these patients is associated with a higher risk of severe adverse events, including toxic death. The calculator will return a dose of 0 mg for patients with severe impairment.
Other major warnings include neutropenia (the most common adverse reaction), hypersensitivity reactions, fluid retention, and cutaneous reactions. Close monitoring is essential.
Frequently Asked Questions
What BSA formulas does the calculator use?
The calculator allows you to choose between the two most commonly used formulas for BSA calculation in oncology: the Du Bois formula (default) and the Mosteller formula.
How does the calculator handle hepatic impairment?
For Mild Impairment (Transaminases >1.5x ULN), the calculator issues a warning to monitor the patient closely, as per prescribing information. For Moderate/Severe Impairment (Bilirubin > ULN), it flags the condition as a contraindication and recommends a dose of 0 mg.
What is dose capping and how does it work?
Dose capping is a practice used to prevent excessive toxicity in patients with a very large BSA. The tool allows capping by a maximum BSA value (e.g., 2.0 m²) or a maximum absolute dose (e.g., 150 mg). If the calculated dose exceeds the set cap, the final dose will be limited to the capped value.
Can I use this for weekly docetaxel dosing?
Yes. While the dosing logic focuses on a single administration, you can calculate the appropriate dose for a weekly regimen by entering the prescribed weekly dose rate (e.g., 35 mg/m²) into the "Prescribed Dose" field after selecting "Custom Regimen".
Why is premedication with Dexamethasone important?
Premedication is crucial to reduce the risk and severity of two common side effects of docetaxel: hypersensitivity reactions and fluid retention (edema). Following the recommended premedication schedule is a standard part of care.
What happens if I enter height in inches or weight in pounds?
The tool automatically converts imperial units (inches, pounds) into metric units (cm, kg) for the BSA calculation. Simply select the correct unit from the dropdown next to the input field.
Does this tool account for renal impairment?
No. Standard prescribing information does not recommend a specific dose adjustment for mild to moderate renal impairment. The tool does not include an input for renal function. Dosing in patients with severe renal impairment should be handled with caution and according to institutional guidelines.
Is the calculated dose ready for administration?
No. This tool is for informational purposes only. All calculations must be independently verified by a qualified healthcare professional (e.g., a pharmacist or oncologist) before a prescription is written or a dose is administered.
References
The information and calculations used in this tool are based on standard clinical practices and official prescribing information. For complete guidance, consult the resources below.
- U.S. Food and Drug Administration (FDA). TAXOTERE (docetaxel) injection, for intravenous use. Full Prescribing Information. View FDA Label
- National Cancer Institute (NCI). Docetaxel - NCI Drug Dictionary. Visit NCI Page
- European Medicines Agency (EMA). Docetaxel - European public assessment report (EPAR). View EMA Summary
- Mosteller RD. Simplified calculation of body-surface area. N Engl J Med. 1987;317(17):1098. View on NEJM

I am a Registered Pharmacist under the Pharmacy Act, 1948, and the founder of PharmacyFreak.com. I hold a Bachelor of Pharmacy degree from Rungta College of Pharmaceutical Science and Research. With a strong academic foundation and practical knowledge, I am committed to providing accurate, easy-to-understand content to support pharmacy students and professionals. My aim is to make complex pharmaceutical concepts accessible and useful for real-world application.
Mail- Sachin@pharmacyfreak.com